Northwest Biotherapeutics reported a net margin of -1,183.77% for the quarter ended Jun 2026. These financial ratios cover 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2010 | Sep2010 | Dec2010 | Mar2011 | Jun2011 | Sep2011 | Dec2011 | Mar2012 | Jun2012 | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EBT Margin | -3,329.43% | -3,520.84% | -4,723.48% | -8,315.53% | -3,249.41% | -1,589.89% | -7,402.49% | -3,816.50% | -3,681.80% | -6,078.17% | -3,753.92% | -4,728.57% | -9,085.28% | -5,043.47% | -12,675.57% | -8,470.50% | -2,403.27% | -2,681.38% | -1,662.21% | ||||||||||||||||||||||||||||||||||||||||||||||
| EBIT Margin | -2,871.14% | -3,048.64% | -4,423.27% | -7,581.55% | -3,044.89% | -1,473.18% | -6,754.73% | -3,405.17% | -3,402.70% | -5,543.66% | -3,424.31% | -4,145.94% | -8,008.23% | -4,616.27% | -11,281.68% | -7,160.00% | -2,009.52% | -2,206.48% | -1,438.04% | ||||||||||||||||||||||||||||||||||||||||||||||
| EBITDA Margin | -2,871.14% | -3,048.64% | -4,423.27% | -7,581.55% | -3,044.89% | -1,473.18% | -6,754.73% | -3,405.17% | -3,402.70% | -5,543.66% | -3,424.31% | -4,145.94% | -8,008.23% | -4,616.27% | -11,281.68% | -7,160.00% | -2,009.52% | -2,206.48% | -1,438.04% | ||||||||||||||||||||||||||||||||||||||||||||||
| Operating Margin | -2,871.14% | -3,048.64% | -4,423.27% | -7,581.55% | -3,044.89% | -1,473.18% | -6,754.73% | -3,405.17% | -3,402.70% | -5,543.66% | -3,424.31% | -4,145.94% | -8,008.23% | -4,616.27% | -11,281.68% | -7,160.00% | -2,009.52% | -2,206.48% | -1,438.04% | ||||||||||||||||||||||||||||||||||||||||||||||
| Net Margin | 1,260.00% | -3,527.05% | -6,219.71% | -15,947.57% | -4,740.03% | -1,255.34% | -7,446.27% | -5,921.43% | -3,217.53% | -6,647.89% | -3,590.20% | -5,463.87% | -12,335.93% | -5,228.80% | -12,166.41% | -13,591.00% | 186.16% | -688.26% | -1,183.77% | ||||||||||||||||||||||||||||||||||||||||||||||
| FCF Margin | -2,772.57% | -3,232.01% | -3,196.86% | -7,958.25% | -1,844.05% | -1,428.64% | -6,353.23% | -3,535.96% | -3,904.72% | -4,452.46% | -3,278.04% | -2,355.46% | -8,770.13% | -2,536.27% | -5,337.40% | -7,047.50% | -2,331.70% | -2,558.30% | -912.89% | ||||||||||||||||||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 28.49M | 34.19M | 35.41M | 29.09M | 29.31M | 31.21M | 32.10M | 30.65M | 29.96M | 29.68M | 28.22M | 28.40M | 28.77M | 28.02M | 27.12M | 28.53M | 30.08M | 55.95M | 80.67M | 78.00M | |||||||||||||||||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 1.52M | 16.18M | 2.56M | -1.40M | -21.25M | -32.88M | -21.04M | -28.18M | -41.94M | -32.33M | -41.84M | -39.58M | -42.65M | -58.33M | -63.29M | -65.80M | -78.22M | -29.06M | -31.69M | -22.69M | |||||||||||||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.05 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.07 | 0.06 | 0.07 | 0.07 | 0.05 | 0.06 | 0.06 | 0.05 | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 | |||||||||||||||||||||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -6.26 | -9.26 | -6.46 | -14.73 | -10.33 | -14.89 | -12.62 | -10.43 | -8.28 | -12.19 | -10.37 | -10.39 | -7.12 | -7.44 | -10.81 | -8.09 | -5.46 | -5.10 | -4.65 | -6.42 | |||||||||||||||||||||||||||||||||||||||||||||
| Debt Ratio | 10.75 | 3.49 | 4.01 | 3.28 | 2.82 | 3.04 | 1.06 | 1.16 | 0.89 | 1.20 | 1.10 | 1.31 | 1.28 | 1.35 | 1.32 | 1.17 | 0.99 | 0.38 | 0.24 | 0.30 | |||||||||||||||||||||||||||||||||||||||||||||
| Times Interest Earned | -6.26 | -9.26 | -6.46 | -14.73 | -10.33 | -14.89 | -12.62 | -10.43 | -8.28 | -12.19 | -10.37 | -10.39 | -7.12 | -7.44 | -10.81 | -8.09 | -5.46 | -5.10 | -4.65 | -6.42 | |||||||||||||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | 258.87 | 3.71 | -46.71 | -21.97 | -22.36 | -29.45 | -0.06 | -0.04 | -0.04 | -57.47 | -0.03 | -0.03 | -0.02 | -11.14 | -0.02 | -0.02 | -0.01 | 285.96 | -99.25 | -33.20 | |||||||||||||||||||||||||||||||||||||||||||||
| Price to SalesP/S | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.77 | 3.14 | 2.54 | 0.00M | 2.18 | 1.02 | 1.13 | 0.00M | 0.83 | 2.63 | 1.79 | 532.35 | 683.10 | 393.02 | ||||||||||||||||||||||||||||||||||||||||||||||
| Price to BookP/B | -3.78 | -5.35 | -5.51 | -7.11 | -6.75 | -6.51 | -0.01 | -0.01 | -0.01 | -12.51 | -0.01 | -0.01 | -0.01 | -3.36 | 0.00 | 0.00 | 0.00 | -5.93 | -6.68 | -7.02 | |||||||||||||||||||||||||||||||||||||||||||||
| Enterprise Value | 1,137.80M | 648.71M | 656.92M | 646.90M | 725.07M | 826.39M | -5.51M | -0.79M | -5.06M | 820.72M | -1.86M | -2.36M | -2.54M | 315.21M | -2.47M | -3.97M | -4.20M | 354.70M | 335.66M | 316.57M | |||||||||||||||||||||||||||||||||||||||||||||
| EV to EBIT | -113.22 | -60.76 | -53.47 | -30.66 | -46.43 | -45.46 | 0.43 | 0.06 | 0.37 | -54.20 | 0.12 | 0.14 | 0.17 | -17.04 | 0.14 | 0.27 | 0.29 | -26.27 | -30.79 | -27.28 | |||||||||||||||||||||||||||||||||||||||||||||
| EV to EBITDA | -113.22 | -60.76 | -53.47 | -30.66 | -46.43 | -45.46 | 0.43 | 0.06 | 0.37 | -54.20 | 0.12 | 0.14 | 0.17 | -17.04 | 0.14 | 0.27 | 0.29 | -26.27 | -30.79 | -27.28 | |||||||||||||||||||||||||||||||||||||||||||||
| Market Capitalization | 1,141.63M | 663.88M | 663.88M | 651.73M | 734.49M | 833.35M | 0.68M | 0.63M | 1.03M | 822.85M | 0.62M | 0.52M | 0.40M | 317.39M | 0.31M | 0.35M | 0.36M | 357.74M | 337.45M | 317.17M | |||||||||||||||||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -117.65 | -51.87 | -50.97 | -42.74 | -44.80 | -75.70 | -0.05 | -0.05 | -0.07 | -47.36 | -0.05 | -0.03 | -0.05 | -15.67 | -0.03 | -0.05 | -0.03 | -22.83 | -26.70 | -43.05 | |||||||||||||||||||||||||||||||||||||||||||||
| EV to FCF | -117.25 | -50.68 | -50.44 | -42.42 | -44.23 | -75.06 | 0.44 | 0.06 | 0.35 | -47.23 | 0.15 | 0.14 | 0.30 | -15.56 | 0.26 | 0.57 | 0.30 | -22.64 | -26.56 | -42.97 | |||||||||||||||||||||||||||||||||||||||||||||
| EV to CFO | -162.24 | -57.68 | -50.66 | -43.59 | -44.99 | -93.39 | 0.49 | 0.07 | 0.36 | -48.40 | 0.15 | 0.15 | 0.31 | -15.62 | 0.26 | 0.59 | 0.30 | -24.02 | -26.83 | -44.16 | |||||||||||||||||||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -2,871.14% | -5,243.98% | -3,048.64% | -4,423.27% | -7,581.55% | -3,044.89% | -1,473.18% | -6,754.73% | -3,405.17% | -3,402.70% | -5,543.66% | -3,424.31% | -4,145.94% | -8,008.23% | -4,616.27% | -11,281.68% | -7,160.00% | -2,009.52% | -2,206.48% | -1,438.04% | |||||||||||||||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 23.04% | 52.93% | 48.01% | 78.34% | 68.74% | 70.87% | 538.09% | 650.85% | 304.00% | 357.53% | 170.31% | 223.83% | 205.10% | 165.24% | 121.69% | 118.04% | 112.25% | 167.59% | 2,323.69% | -1,083.74% | |||||||||||||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -247.64% | -168.80% | -143.71% | -206.95% | -224.09% | -234.69% | -227.59% | -213.34% | -212.79% | -204.69% | -226.89% | -240.48% | -242.14% | -265.04% | -280.00% | -257.26% | -244.19% | -122.63% | -78.02% | -76.61% |